Alessandro Rambaldi to Prospective Studies
This is a "connection" page, showing publications Alessandro Rambaldi has written about Prospective Studies.
Connection Strength
0.068
-
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
Score: 0.038
-
Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Bone Marrow Transplant. 2018 09; 53(9):1193-1197.
Score: 0.008
-
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey. Clin Infect Dis. 2017 Nov 13; 65(11):1884-1896.
Score: 0.007
-
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs. Leuk Res. 2017 12; 63:34-40.
Score: 0.007
-
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen. Biol Blood Marrow Transplant. 2017 Jul; 23(7):1102-1109.
Score: 0.007